Nivolumab-induced Acute Fibrinous and Organizing Pneumonia (AFOP)
Sign Up to like & getrecommendations! Published in 2017 at "Internal Medicine"
DOI: 10.2169/internalmedicine.8271-16
Abstract: Although nivolumab is known to cause immune-related interstitial lung diseases (ILD), the detailed characteristics of ILD are still not fully understood. A 68-year-old man was treated with nivolumab because of unresectable sinonasal melanoma, he achieved… read more here.
Keywords: organizing pneumonia; acute fibrinous; fibrinous organizing; pneumonia afop ... See more keywords